Clinical and Neurobiological Aspects of TAO Kinase Family in Neurodevelopmental Disorders

被引:7
|
作者
Hu, Chun [1 ,2 ]
Feng, Pan [1 ,2 ]
Yang, Qian [1 ,2 ]
Xiao, Lin [1 ,2 ]
机构
[1] South China Normal Univ, Minist Educ, Key Lab Brain Cognit & Educ Sci, Guangzhou, Peoples R China
[2] South China Normal Univ, Inst Brain Res & Rehabil, Guangzhou, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
TAO kinase; neurodevelopmental disorders; neuron; cytoskeleton; de novo mutations; therapy;
D O I
10.3389/fnmol.2021.655037
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Despite the complexity of neurodevelopmental disorders (NDDs), from their genotype to phenotype, in the last few decades substantial progress has been made in understanding their pathophysiology. Recent accumulating evidence shows the relevance of genetic variants in thousand and one (TAO) kinases as major contributors to several NDDs. Although it is well-known that TAO kinases are a highly conserved family of STE20 kinase and play important roles in multiple biological processes, the emerging roles of TAO kinases in neurodevelopment and NDDs have yet to be intensively discussed. In this review article, we summarize the potential roles of the TAO kinases based on structural and biochemical analyses, present the genetic data from clinical investigations, and assess the mechanistic link between the mutations of TAO kinases, neuropathology, and behavioral impairment in NDDs. We then offer potential perspectives from basic research to clinical therapies, which may contribute to fully understanding how TAO kinases are involved in NDDs.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Clinical impact of splicing in neurodevelopmental disorders
    Stephan J. Sanders
    Grace B. Schwartz
    Kyle Kai-How Farh
    Genome Medicine, 12
  • [32] Clinical impact of splicing in neurodevelopmental disorders
    Sanders, Stephan J.
    Schwartz, Grace B.
    Farh, Kyle Kai-How
    GENOME MEDICINE, 2020, 12 (01)
  • [33] Anxiety-depressive disorders in children: Neurobiological and neurohormonal aspects
    Mykhailova, E.
    Matkovska, T.
    Reshetovska, N.
    Goloborodko, A.
    EUROPEAN PSYCHIATRY, 2017, 41 : S455 - S455
  • [34] Medicinal Plant Materials in the Treatment of Anxiety Disorders: Neurobiological Aspects
    Golyszny, Milosz
    Obuchowicz, Ewa
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2018, 24 (05) : 44 - 57
  • [35] THE CHILD WITH AUTISM SPECTRUM DISORDERS (ASDS) : BEHAVIORAL AND NEUROBIOLOGICAL ASPECTS
    Parisi, Lucia
    Di Filippo, Teresa
    Roccella, Michele
    ACTA MEDICA MEDITERRANEA, 2015, 31 (06): : 1187 - 1194
  • [36] Neurobiological aspects of the etiology and pathophysiology of obsessive-compulsive disorders
    Kordon, A
    Hohagen, F
    PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, 2000, 50 (11) : 428 - 434
  • [37] Attachment style: The neurobiological substrate, interaction with genetics and role in neurodevelopmental disorders risk pathways
    Antonucci, Linda A.
    Taurisano, Paolo
    Coppola, Gabrielle
    Cassibba, Rosalinda
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2018, 95 : 515 - 527
  • [38] The Effect of Neurodevelopmental Disorders Characteristics on Aspects of Social Functioning
    Tal-Saban, M.
    Zaguri-Vittenberg, S.
    Ozeri, E.
    Yochman, A.
    PHYSICAL & OCCUPATIONAL THERAPY IN PEDIATRICS, 2024, 44 (06) : 783 - 797
  • [39] CLINICAL AND NEUROBIOLOGICAL ASPECTS OF LONG-TERM PSYCHOPHARMACOTHERAPY
    BOURIN, M
    BRADWEJN, J
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1991, 36 (04): : 260 - 264
  • [40] NEUROBIOLOGICAL ASPECTS OF PTSD - REVIEW OF CLINICAL AND PRECLINICAL STUDIES
    KRYSTAL, JH
    KOSTEN, TR
    SOUTHWICK, S
    MASON, JW
    PERRY, BD
    GILLER, EL
    BEHAVIOR THERAPY, 1989, 20 (02) : 177 - 198